Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
FDA approves belzutifan for advanced kidney cancer
The Food and Drug Administration (FDA) in the United States [...]
ESMO 2023: Belzutifan for the treatment of advanced kidney cancer
Treatments for people with metastatic kidney cancer have changed over [...]
Belzutifan plus cabozantinib combination shows promising results in kidney cancer
Kidney cancers often have mutations in a gene called the [...]
Cabozantinib after immunotherapy in advanced kidney cancer
This recent retrospective study included 84 patients with metastatic renal [...]
Axitinib effective as a third-line treatment for kidney cancer
A recent study published in the journal In Vivo assessed [...]
